Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Technical Report
  • Published:

Positive quantitative PCR detecting Fusarium solani in a case of mixed invasive fungal disease due to Mucorales and Fusarium solani

Abstract

We present a case of invasive fungal co-infection in a young patient treated for an acute myeloid leukemia and having undergone a twice-haploid matched unrelated donor hematopoietic stem cell transplantation (HSCT) with two different donors. A mucormycosis diagnosis was made shortly after the patient’s admission using imagery and specific Mucorales qPCR which was treated with liposomal amphotericin B and posaconazole. Twenty days later, a blood culture was positive for Fusarium solani, and disseminated cutaneous lesions appeared. The antifungal treatment was changed to liposomal amphotericin B and voriconazole. Thanks to a complete hematological reconstitution and despite a co-infection with two aggressive filamentous opportunistic fungi, the patient recovered. We took advantage of this clinical case to test a specific Fusarium solani qPCR, which proved to be promising when performed retrospectively on some of the patient samples.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Similar content being viewed by others

References

  1. Bellanger AP, Millon L, Berceanu A, Grenouillet F, Grenouillet FE, Larosa F, et al. Combining Aspergillus mitochondrial and ribosomal QPCR, in addition to galactomannan assay, for early diagnosis of invasive aspergillosis in hematology patients. Med Mycol. 2015;53:760–4.

    Article  CAS  Google Scholar 

  2. Millon L, Herbrecht R, Grenouillet F, Morio F, Alanio A, Letscher-Bru V. French Mycosis Study Group et al. Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF). Clin Microbiol Infect. 2016;22:810e1–e8.

    Article  CAS  Google Scholar 

  3. Millon L, Scherer E, Rocchi S, Bellanger AP. Molecular strategies to diagnose mucormycosis. J Fungi. 2019;5:24–31.

    Article  CAS  Google Scholar 

  4. Kontoyiannis DP, Yang H, Song J, Kelkar SS, Yang X, Azie N, et al. Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective study. BMC Infect Dis. 2016;16:730–6.

    Article  Google Scholar 

  5. Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DCM, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019;25:26–34.

    Article  CAS  Google Scholar 

  6. Nucci F, Nouér SA, Capone D, Anaissie E, Nucci M. Fusariosis. Semin Respir Crit Care Med. 2015;36:706–14.

    Article  Google Scholar 

  7. Yu J, Chen Y, Fang J, Zhang K. Successful treatment of disseminated fusariosis in a patient with acute lymphoblastic leukemia: a case report and literature review. Medicine. 2019;98:16246–52.

    Article  Google Scholar 

  8. Montagna MT, Lovero G, Coretti C, Martinelli D, Delia M, De Giglio O, et al. SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients. Infection. 2014;42:141–51.

    Article  CAS  Google Scholar 

  9. Lortholary O, Fernández-Ruiz M, Perfect JR. The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis). J Antimicrob Chemother. 2016;71:31–6.

    Article  Google Scholar 

  10. Mikulska M, Furfaro E, Del Bono V, Gualandi F, Raiola AM, Molinari MP, et al. Galactomannan testing might be useful for early diagnosis of fusariosis. Diagn Microbiol Infect Dis. 2012;72:367–9.

    Article  CAS  Google Scholar 

  11. EPA Technology for mold identification an enumeration. Microbiological and Chemical Exposure assessment. https://irp-cdn.multiscreensite.com/c4e267ab/files/uploaded/gCQnkBNWQuSD96fPIikY_EPA_TechnologyforMoldIdentificationandEnumeration.pdf.

  12. Koehler P, Tacke D, Cornely OA. Bone and joint infections by mucorales, scedosporium, fusarium and even rarer fungi. Crit Rev Microbiol. 2016;42:158–71.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Pamela Albert for her editorial assistance. We thank Dr. Olivier Lortholary for his advice on antifungal therapeutic management regarding the MIC result obtained from the National Reference Center (Paris, France).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anne-Pauline Bellanger.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bellanger, AP., Rocchi, S., Berceanu, A. et al. Positive quantitative PCR detecting Fusarium solani in a case of mixed invasive fungal disease due to Mucorales and Fusarium solani. Bone Marrow Transplant 55, 873–876 (2020). https://doi.org/10.1038/s41409-020-0819-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41409-020-0819-3

Search

Quick links